A biostatistics consultant on the pattern she keeps seeing: sponsors skipping steps to chase accelerated approval.
- To Pick The Right Medical LLM, First Assess Your Readiness
- Clinical Trial Tech Fails On Systems, Not Software
- Inside A Sponsor-Site Relationship That Actually Worked
- Real-World Data Won't Replace Trials. Here's Its Real Job
- Inside Virtua Health's Pipeline For Anonymizing Trial Imaging Data
- What Ecological Momentary Assessment Taught Us About Real-World Hearing Outcomes
- AI Governance Is Becoming A Competitive Edge In Trials
- Why The Biostatistician's Seat At The Table Keeps Vanishing
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Pioneering Clinical Research For Native American Communities In South Dakota
Lynn Bartholow is transforming clinical research for Native American populations. Explore her journey into clinical research and efforts to build trust and foster participation and community engagement.
-
Vanderbilt's Advice For Sponsors: How To Make Working With Your EDC Easier For Sites
Learn how research sites like Vanderbilt University Medical Center speed study timelines and drive higher quality data entry with a modern EDC.
-
Endpoint Reliability And eCOA Solutions Facilitate CNS Trial Success
A Japan-based pharmaceutical development company utilized Signant's eCOA solutions and knowledge to ensure the reliability of endpoints in their Phase 3 and extended-duration CNS trials.
-
What Does EDC Look Like In 2024 And Beyond?
Read along as industry experts from TrialKit offer insights into the anticipated developments and challenges surrounding electronic data capture.
-
Digital Outcome Measures Approved As Primary Endpoint In Cardiopulmonary Study
Discover how a clinical development program was saved using objective, continuous digital outcome measures.
-
Real-Time Review Is The Most Underrated FDA Story Of The Year
The FDA’s real-time review pilot signals a massive shift in clinical operations, where continuously regulator-ready data becomes the foundation of future trial execution.
-
Implementing Cognizant® Shared Investigator Platform: Lessons From The Field
One leading oncology healthcare system and research institution has recently successfully implemented Cognizant SIP and shares its best practices around planning for and implementing Cognizant SIP given such a large footprint.
-
EU Annex 11: How To Stay Compliant
EU Annex 11 lays out the European Union’s regulations for using computerized systems during clinical trials. Learn how sponsors and sites seeking treatment approval in the EU must follow Annex 11.
-
Clinical Trial Governance A Strategic Look At KPIs From An RTSM Perspective
Learn how data-driven metrics improve oversight, mitigate risk, and accelerate execution while safeguarding supply continuity and patient safety.
-
Flexible By Design: Support For Early-Phase Oncology Trial
Shifting cohorts, doses, and protocols challenge early-phase oncology trials. Learn how adaptable technology keeps studies on track.
RECENT NEWSLETTERS
- 10.08.26 -- AI, RTSM, And Trial Systems Are Still Breaking Down
- 10.03.26 -- Best Of September: AI, Wearables, And Trial Workflow Gaps
- 10.01.26 -- AI, Data Integrity, And Wireless Gaps Are Reshaping Trials
- 09.24.26 -- AI, Wearables, And CRA Workflows Are Exposing Trial Gaps
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps